Leveragen Partners with Cell Signaling Technology to Advance Reagent Antibody Innovation with Proprietary Nanobody Technology
Leveragen Inc., a Boston-based biotechnology company specializing in next-generation genetic models for antibody discovery, ...
Radiopharm Theranostics: Radiotherapeutic Biotech With PD-L1 And HER2 Targeting
Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...
Medscape3d
Advancing HS Care: Applying Key Lessons From AAD 2025 to the Clinic
Dr. Christopher J. Sayed shares insights on the growing emphasis on personalized care for hidradenitis suppurativa.
Labmate Online13d
Deciphering the code of chemical and biological processes: The role of AI in laboratory research
This article explores the transformative role of artificial intelligence (AI) in deciphering the complex molecular and ...
Technology Networks5d
Revolutionizing Proteomics: How Labs Can Transform Protein Characterization Workflows
This article explores how automation is transforming proteomics by streamlining proteoform analysis, boosting throughput and ...
EurekAlert!4d
The Protein Society announces its 2025 Award Recipients
The Protein Society, the premier international society dedicated to supporting protein research, announces the winners of the 2025 Protein Society Awards, which will be recognized  at the 39th Annual ...
Yahoo Finance27d
WuXi Biologics Launches EffiXâ„¢ Microbial Expression Platform to Boost Recombinant Protein and Plasmid DNA Production
nanobodies, enzymes, cytokines, various antigens, polypeptides, and plasmid DNA (pDNA) — all of which present significant opportunities for the development of next-generation therapies.
Business Wire24d
Proteintech Unveils Next-Gen 3D Epitope Mapping to Accelerate Life Science Research
About Proteintech Proteintech Group Inc., founded in 2001, is a leading manufacturer of antibodies, proteins, nanobodies, and immunoassays. Proteintech has the largest proprietary portfolio of ...